Literature DB >> 67713

Development of an intravenous gamma-globulin with Fc activities. I. Preparation and characterization of S-sulfonated human gamma-globulin.

Y Masuho, K Tomibe, K Matsuzawa, A Ohtsu.   

Abstract

S-sulfonated gamma-globulin (S-GG) was prepared by treating gamma-globulin with sulfite and tetrathionate ions. About four interchain disulfide bonds were selectively cleaved to give S-sulfonate groups. Although the above treatment strongly suppresses anticomplementary activity and nonspecific skin reactivity, the resulting S-GG retains high antibody activity. Furthermore, S-GG was found to maintain satisfactory levels for prolonged periods in vivo. The physicochemical and antigenic analyses of S-GG suggest that the S-sulfonation induces structural modification only at restricted sites.

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 67713     DOI: 10.1111/j.1423-0410.1977.tb00622.x

Source DB:  PubMed          Journal:  Vox Sang        ISSN: 0042-9007            Impact factor:   2.144


  9 in total

Review 1.  New and old aspects of immunoglobulin application. The use of intravenous IgG as prophylaxis and for treatment of infections.

Authors:  L Hammarström; C I Smith
Journal:  Infection       Date:  1990 Sep-Oct       Impact factor: 3.553

2.  Effect of trastuzumab interchain disulfide bond cleavage on Fcγ receptor binding and antibody-dependent tumour cell phagocytosis.

Authors:  Mami Suzuki; Ayaka Yamanoi; Yusuke Machino; Michiko Ootsubo; Ken-ichi Izawa; Junya Kohroki; Yasuhiko Masuho
Journal:  J Biochem       Date:  2015-08-08       Impact factor: 3.387

3.  Clinical trial of sulfonated immunoglobulin preparation for intravenous administration. I. Replacement therapy for primary immunodeficiency syndromes.

Authors:  N Kobayashi; N Gohya; S Matsumoto
Journal:  Eur J Pediatr       Date:  1981-05       Impact factor: 3.183

4.  [Problems of intravenous gammaglobulin therapy (author's transl)].

Authors:  J Ring; K H Duswald
Journal:  Klin Wochenschr       Date:  1980-08-15

5.  Protective effects of S-sulfonated human gamma globulin against experimental infections in mice.

Authors:  H Tomioka; Y Iwamura; Y Suzuki; S Ohtomo; Y Hashimoto
Journal:  Infect Immun       Date:  1980-11       Impact factor: 3.441

6.  Effect of immunoglobulin G (IgG) interchain disulfide bond cleavage on efficacy of intravenous immunoglobulin for immune thrombocytopenic purpura (ITP).

Authors:  Y Machino; H Ohta; E Suzuki; S Higurashi; T Tezuka; H Nagashima; J Kohroki; Y Masuho
Journal:  Clin Exp Immunol       Date:  2010-10-05       Impact factor: 4.330

7.  Modification of immune complexes deposited in glomeruli in tissue sections treated with sulfonized gamma-globulin.

Authors:  M Sato; H Kojima; S Koshikawa
Journal:  Clin Exp Immunol       Date:  1986-06       Impact factor: 4.330

8.  Prophylactic treatment with sulphonated immunoglobulin G attenuates development of mechanical allodynia-like response in mice with neuropathic pain.

Authors:  Wataru Yamamoto; Yasuhiro Itano; Tsunefumi Kobayashi; Daishiro Miura; Yoshinori Kasahara
Journal:  J Vet Med Sci       Date:  2015-08-29       Impact factor: 1.267

Review 9.  Intravenous immunoglobulins: evolution of commercial IVIG preparations.

Authors:  John A Hooper
Journal:  Immunol Allergy Clin North Am       Date:  2008-11       Impact factor: 3.479

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.